Kitazato Corporation (368A) Cash flow
Market cap
¥48B
P/E ratio
12.1x
Kitasato Corporation develops and manufactures medical devices and reagents for reproductive medicine including IVF and egg freezing, serving hospitals and clinics in over 110 countries worldwide.
| 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Depreciation & amortization | 162 | 177 | 175 | 190 |
| Cash from operations | 2,130 | 4,500 | 3,526 | 3,870 |
| Capital expenditures | -76 | -76 | -899 | -239 |
| Cash from investing | -89 | -89 | -880 | -237 |
| Payments for dividends | -1,200 | -2,000 | -1,600 | -1,640 |
| Repayments of term debt | -19 | - | - | - |
| Cash from financing | -1,270 | -2,072 | -1,658 | -1,738 |